Figure 2From: Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials Reverse cumulative curves of haemagglutinin inhibition (HI) antibody titres in adults and children (ATP immunogenicity cohorts for each time point). See Table 1 for details of treatment groups in each study.Back to article page